Work

AML-027 The LD-VenEx Phase II Clinical Trial: An ex Vivo Flow Cytometry Based-Drug Screening of AML Patient Samples

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)00979-5

Authors: Niveditha Umesh Katyayini, Sandra Leigh Gordon, Heikki A Kuusanmäki, Pilar Ayuda Durán, Jorrit Martijn Enserink, Krister Wennerberg

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4386282024

Cites:

Cited by:

Related to: 10